Is mutated serine hydroxymethyltransferase (SHMT) involved in the etiology of neural tube defects?

被引:125
|
作者
Heil, SG
Van der Put, NMJ
Waas, ET
den Heijer, M
Trijbels, FJM
Blom, HJ
机构
[1] Univ Nijmegen, Med Ctr, Lab Pediat & Neurol, Dept Pediat, NL-6500 HB Nijmegen, Netherlands
[2] Univ Nijmegen, Med Ctr, Dept Internal Med, Div Endocrinol, NL-6500 HB Nijmegen, Netherlands
关键词
serine hydroxymethyltransferase (SHMT); folate; RBC folate; plasma folate; homocysteine (Hcy); neural tube defects (NTD); SSCP; mutation;
D O I
10.1006/mgme.2001.3175
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Neural tube defects (NTD) arise in the first weeks of pregnancy due to a combination of environmental and genetic factors. In mothers of children with NTD elevated homocysteine (Hcy) levels and decreased plasma folate levels were observed, which suggests a defect in the folate-dependent Hey metabolism, Therefore, mutations in genes coding for enzymes of this metabolism could be involved in NTD. Serine hydroxymethyltransferase (SHMT) catalyzes the reversible reaction of serine and tetrahydrofolate (THF) to glycine and 5,10-methylene THF. Two different isoforms of SHMT are known, one is present in the cytosol (cSHMT) and the other in the mitochondrion (mSHMT). Theoretically, mutated SHMT could lead to elevated Hey levels and to an altered distribution of the different folate derivatives and might therefore become a risk. factor for NTD. This study concerns the molecular genetic analysis of genes coding for both isoforms of the SHMT enzyme by single-stranded conformation polymorphism analysis. Several mutations as well as polymorphisms were found in both genes. The relevance of two variations, the 1420 C >T mutation of the cytosolic isoform and the 4-bp deletion of the mitochondrial isoform (delTCTT 1721-1724), to NTD risk was tested in a study group, which consisted of 109 NTD patients, 120 mothers of children with NTD, and 420 controls. Neither of the two polymorphisms led to an increased risk of NTD. In mothers with the 1420 cc genotype, significant increased Hey levels are present. Also, significantly decreased red blood cell folate and plasma folate levels were present in individuals with the 1420 CC genotype. Probably, the 1420 C >T polymorphism causes a shift in distribution of the different folate derivatives. The 4-bp deletion of the mSHMT gene did not lead to altered Key or folate levels. So far, the results of this study provide no direct evidence for a role of defective SHMT functioning in NTD. Still, the influence of the 1420 C >T polymorphism of the cSHMT gene on the folate-related risk of NTD needs further investigation. (C) 2001 Academic Press.
引用
收藏
页码:164 / 172
页数:9
相关论文
共 50 条
  • [1] The etiology of neural tube defects
    Scott, JM
    Weir, DG
    Molloy, A
    McPartlin, J
    Daly, L
    Kirke, P
    Conley, H
    Lee, J
    Mills, J
    HOMOCYSTEINE METABOLISM: FROM BASIC SCIENCE TO CLINICAL MEDICINE, 1997, : 133 - 136
  • [2] Targeting serine hydroxymethyltransferase 2 (SHMT2) suppresses hepatocarcinoma
    Woo, Chern Chiuh
    Chen, Way Cherng
    Lee, Teck Hock Philip
    CANCER RESEARCH, 2016, 76
  • [3] Potent Inhibitors of Plasmodial Serine Hydroxymethyltransferase (SHMT) Featuring a Spirocyclic Scaffold
    Schwertz, Geoffrey
    Witschel, Matthias C.
    Rottmann, Matthias
    Leartsakulpanich, Ubolsree
    Chitnumsub, Penchit
    Jaruwat, Aritsara
    Amornwatcharapong, Watcharee
    Ittarat, Wanwipa
    Schafer, Anja
    Aponte, Raphael A.
    Trapp, Nils
    Chaiyen, Pimchai
    Diederich, Francois
    CHEMMEDCHEM, 2018, 13 (09) : 931 - 943
  • [4] Roles of Mitochondrial Serine Hydroxymethyltransferase 2 (SHMT2) in Human Carcinogenesis
    Zeng, Yuanyuan
    Zhang, Jie
    Xu, Mengmeng
    Chen, Fuxian
    Zi, Ruidong
    Yue, Jicheng
    Zhang, Yanan
    Chen, Nannan
    Chin, Y. Eugene
    JOURNAL OF CANCER, 2021, 12 (19): : 5888 - 5894
  • [5] SERINE HYDROXYMETHYLTRANSFERASE (SHMT) AS A PRECIOUS INDICATOR OF ANTIPROLIFERATIVE OR IMMUNOSUPPRESSIVE POTENCY OF VARIOUS COMPOUNDS
    TRAKATELLIS, A
    EXINDARI, M
    HAITOGLOU, CS
    CHRISTODOULOU, D
    DIMITRIADOU, A
    INTERNATIONAL JOURNAL OF IMMUNOPATHOLOGY AND PHARMACOLOGY, 1995, 8 (01): : 31 - 37
  • [6] Human Serine Hydroxymethyltransferase 2 (SHMT2) linteracts with hnRNP D
    Choi, Mieyoung
    Genes & Genomics, 2008, 30 (06) : 541 - 548
  • [7] TRANSCOBALAMINS IN THE ETIOLOGY OF NEURAL-TUBE DEFECTS
    MAGNUS, P
    MAGNUS, EM
    BERG, K
    CLINICAL GENETICS, 1991, 39 (04) : 309 - 310
  • [8] Neural tube defects: Prevalence, etiology and prevention
    Kondo, Atsuo
    Kamihira, Osamu
    Ozawa, Hideo
    INTERNATIONAL JOURNAL OF UROLOGY, 2009, 16 (01) : 49 - 57
  • [9] Structural basis of inhibition of the human serine hydroxymethyltransferase SHMT2 by antifolate drugs
    Scaletti, Emma
    Jemth, Ann-Sofie
    Helleday, Thomas
    Stenmark, Pal
    FEBS LETTERS, 2019, 593 (14) : 1863 - 1873
  • [10] Is mutated MTHFR a risk factor for neural tube defects?
    Posey, DL
    Khoury, MJ
    Mulinare, J
    Adams, MJ
    Ou, CY
    LANCET, 1996, 347 (9002): : 686 - 687